Category: Cardiac Implants
Boston Scientific presents data at the Heart Rhythm Society's annual meeting showing that its Watchman anti-stroke device lowers costs compared with the blood thinner warfarin and aspirin.
Data from a study on patients whose left atrial appendage was treated with SentreHeart's Lariat ligation device show that 20% of patients developed leaks, with 3 leading to neurological events.
A study by researchers from the Texas Cardiac Arrhythmia Institute revealed a 20% rate of atrial leak development after 1 year in patients treated with SentreHeart's Lariat ligation device.
Medtronic launches a clinical trial of its Reveal Linq cardiac monitor to study in-office implantation of the device.
The FDA issues a Class I recall of Maquet's TigerPaw left atrial appendage closure device.
Boston Scientific touts the 1st commercial implantations of its Watchman anti-stroke heart implant.
Shares of Boston Scientific jump today after the FDA approves its Watchman anti-stroke device.
Investors sent shares of Boston Scientific (NYSE:BSX) up nearly 4% today after the medical device company said the FDA approved its long-delayed Watchman anti-stroke device.
A retrospective analysis of St. Jude Medical's CardioMEMS HF implantable heart monitor shows it helps reduce death and hospitalization rates for heart failure patients.